S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.23%) $83.66
Gas
(-1.16%) $1.619
Gold
(0.10%) $2 349.60
Silver
(-0.07%) $27.52
Platinum
(0.25%) $924.40
USD/EUR
(0.36%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.14%) $0.800
USD/RUB
(-0.07%) $92.11

リアルタイムの更新: Coloplast A/S [CLPBY]

取引所: OTC セクター: Healthcare 産業: Medical Instruments & Supplies
最終更新日時27 4月 2024 @ 04:46

-0.97% $ 12.46

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 04:46):

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally...

Stats
本日の出来高 33 842.00
平均出来高 113 079
時価総額 27.92B
EPS $0.598 ( 2023-06-30 )
次の収益日 ( $0.0800 ) 2024-05-09
Last Dividend $0.0740 ( 2023-05-19 )
Next Dividend $0 ( N/A )
P/E 38.93
ATR14 $0.0390 (0.31%)

ボリューム 相関

長: -0.01 (neutral)
短: -0.69 (moderate negative)
Signal:(49.27) Neutral

Coloplast A/S 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Coloplast A/S 相関 - 通貨/商品

The country flag 0.44
( neutral )
The country flag 0.43
( neutral )
The country flag 0.00
( neutral )
The country flag 0.34
( neutral )
The country flag -0.27
( neutral )
The country flag -0.54
( weak negative )

Coloplast A/S 財務諸表

Annual 2023
収益: $24.50B
総利益: $16.33B (66.64 %)
EPS: $22.21
FY 2023
収益: $24.50B
総利益: $16.33B (66.64 %)
EPS: $22.21
FY 2022
収益: $22.58B
総利益: $15.53B (68.78 %)
EPS: $22.15
FY 2021
収益: $19.43B
総利益: $13.31B (68.53 %)
EPS: $2.27

Financial Reports:

No articles found.

Coloplast A/S Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0.210
(N/A)
$0
(N/A)
$0.0740
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Coloplast A/S Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 6.57 - average (85.65%) | Divividend Growth Potential Score: 3.44 - Decrease likely (31.14%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0810 2021-05-14
Last Dividend $0.0740 2023-05-19
Next Dividend $0 N/A
Payout Date 2023-05-30
Next Payout Date N/A
# dividends 5 --
Total Paid Out $0.649 --
Avg. Dividend % Per Year 0.00% --
Score 2.55 --
Div. Sustainability Score 6.57
Div.Growth Potential Score 3.44
Div. Directional Score 5.00 --
Next Divdend (Est)
(2024-10-01)
$0.00796 Estimate 3.61 %
Dividend Stability
0.29 Very Poor
Dividend Score
2.55
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SOUHY Ex Dividend Junior 2023-09-14 Annually 0 0.00%
HFBA Ex Dividend Junior 2023-09-14 Semi-Annually 0 0.00%
ANSLY Ex Dividend Knight 2023-08-23 Semi-Annually 0 0.00%
NSARO Ex Dividend Knight 2023-07-07 Quarterly 0 0.00%
CYFL Ex Dividend Knight 2023-09-05 Quarterly 0 0.00%
THYCF Ex Dividend Junior 2023-09-28 Annually 0 0.00%
IGGHY Ex Dividend Knight 2023-09-21 Semi-Annually 0 0.00%
BDULF Ex Dividend Knight 2023-09-12 Annually 0 0.00%
PPWLM Ex Dividend Junior 2023-07-19 Quarterly 0 0.00%
EKTAY Ex Dividend Knight 2023-08-25 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1951.5006.119.16[0 - 0.5]
returnOnAssetsTTM0.1001.2006.667.99[0 - 0.3]
returnOnEquityTTM0.4241.5006.409.60[0.1 - 1]
payoutRatioTTM0.957-1.0000.433-0.433[0 - 1]
currentRatioTTM0.5320.800-2.34-1.871[1 - 3]
quickRatioTTM0.3240.800-2.80-2.24[0.8 - 2.5]
cashRatioTTM0.04841.500-0.842-1.263[0.2 - 2]
debtRatioTTM0.445-1.5002.58-3.87[0 - 0.6]
interestCoverageTTM9.311.0007.667.66[3 - 30]
operatingCashFlowPerShareTTM25.302.001.5683.14[0 - 30]
freeCashFlowPerShareTTM19.612.000.1950.389[0 - 20]
debtEquityRatioTTM1.430-1.5004.28-6.42[0 - 2.5]
grossProfitMarginTTM0.6671.0002.212.21[0.2 - 0.8]
operatingProfitMarginTTM0.2731.0006.536.53[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2561.0009.699.69[0.2 - 2]
assetTurnoverTTM0.5150.8009.907.92[0.5 - 2]
Total Score6.57

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM3.901.0009.710[1 - 100]
returnOnEquityTTM0.4242.507.699.60[0.1 - 1.5]
freeCashFlowPerShareTTM19.612.003.460.389[0 - 30]
dividendYielPercentageTTM0.3531.5001.1650[0 - 0.4]
operatingCashFlowPerShareTTM25.302.001.5683.14[0 - 30]
payoutRatioTTM0.9571.5000.433-0.433[0 - 1]
pegRatioTTM0.02901.500-3.140[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2211.0006.970[0.1 - 0.5]
Total Score3.44

Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。